help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 24, 2006
Endocrinology, doi:10.1210/en.2006-0590
A more recent version of this article appeared on December 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
147/12/5845    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kester, M. H.A.
Right arrow Articles by Visser, T. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kester, M. H.A.
Right arrow Articles by Visser, T. J.

Submitted on May 4, 2006
Accepted on August 14, 2006

Regulation of Type III Iodothyronine Deiodinase Expression in Human Cell Lines

Monique H.A. Kester, George G.J.M. Kuiper, Rogier Versteeg, and Theo J. Visser*

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Human Genetics, Academic Medical Center, Amsterdam, The Netherlands

* To whom correspondence should be addressed. E-mail: t.j.visser{at}erasmusmc.nl.

Type I and type II iodothyronine deiodinase (D1 and D2) catalyze the activation of the prohormone T4 to the active hormone T3; type III iodothyronine deiodinase (D3) catalyzes the inactivation of T4 and T3. D3 is highly expressed in brain, placenta, pregnant uterus and fetal tissues, and plays an important role in regulating thyroid hormone bioavailability during fetal development. We examined the activity of the different deiodinases in human cell lines, and investigated the regulation of D3 activity and mRNA expression in these cell lines, as well as its possible co-expression with neighboring genes Dlk1 and Dio3os, which may also be especially important during development.

D1 activity and mRNA was only found in HepG2 hepatocarcinoma cells, and D2 activity was observed in none of the cell lines. D3 activity and mRNA was found in ECC-1 endometrium carcinoma cells, MCF-7 mammacarcinoma cells, WRL-68 embryonic liver cells, and SH-SY5Y neuroblastoma cells, but not in the HepG2 hepatocarcinoma cell line or in any choriocarcinoma or astrocytoma cell line. We demonstrated that the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) increased D3 activity 2 to 9-fold in ECC-1, MCF-7, WRL-68, and SH-SY5Y cells. Estradiol increased D3 activity 3-fold in ECC-1, but not in any other cells. Dexamethasone decreased D3 activity in WRL-68 cells only in the absence of fetal calf serum. Incubation with retinoids increased D3 activity 2- to 3-fold in ECC-1, WRL-68 and MCF-7 cells, but decreased D3 activity in SH-SY5Y cells. D3 expression in the different cells was not affected by cAMP or thyroid hormone. Interestingly, D3 mRNA expression in the different cell lines strongly correlated with Dio3os mRNA expression, and in a large set of neuroblastoma cell lines also with Dlk1 expression.

In conclusion, we identified different human D3-expressing cell lines, in which the regulation of D3 expression is cell type-specific. Our data suggest that estradiol may be one of the factors contributing to the induction of D3 activity in the pregnant uterus, and that besides gene-specific regulatory elements, also more distant common regulatory elements may be involved in the regulation of D3 expression.


Key words: Deiodination • Retinoids • Estradiol • Phorbol ester • Dlk1




This article has been cited by other articles:


Home page
EndocrinologyHome page
M. H. A. Kester, M. J. M. Toussaint, C. A. Punt, R. Matondo, A. M. Aarnio, V. M. Darras, M. E. Everts, A. de Bruin, and T. J. Visser
Large Induction of Type III Deiodinase Expression After Partial Hepatectomy in the Regenerating Mouse and Rat Liver
Endocrinology, January 1, 2009; 150(1): 540 - 545.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Piehl, T. Heberer, G. Balizs, T. S. Scanlan, R. Smits, B. Koksch, and J. Kohrle
Thyronamines Are Isozyme-Specific Substrates of Deiodinases
Endocrinology, June 1, 2008; 149(6): 3037 - 3045.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. W. A. Smit, M. P. M. Stokkel, A. M. Pereira, J. A. Romijn, and T. J. Visser
Bexarotene-Induced Hypothyroidism: Bexarotene Stimulates the Peripheral Metabolism of Thyroid Hormones
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2496 - 2499.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society